Switching Guanfacine from Morning to Night Dosing
Simply take your current morning dose at bedtime instead—no gradual transition or dose adjustment is needed. Guanfacine is designed for once-daily administration and can be taken at either time of day without requiring a washout period or titration when switching timing 1.
Why Bedtime Dosing is Preferred
Evening administration is generally preferable for guanfacine due to its side effect profile 1. The most common adverse effects—somnolence (occurring in up to 38.6% of patients), fatigue (15.2%), and sedation—are better tolerated when they occur during sleep rather than interfering with daytime functioning 2.
The evidence shows:
- No significant difference in efficacy between morning versus evening administration was found in clinical studies 1
- Guanfacine provides "around-the-clock" effects with once-daily dosing due to its long elimination half-life 1
- The medication reaches steady-state plasma concentrations within 4 days 3
How to Make the Switch
On the day you decide to switch:
- Skip your morning dose
- Take your usual dose at bedtime (6:00-10:00 PM) that same evening
- Continue bedtime dosing thereafter
There is no need to:
- Gradually taper the morning dose
- Split doses temporarily
- Adjust your total daily dose
- Take a "bridging" dose
Important Safety Considerations
Monitor for cardiovascular effects during the first few days after switching, as guanfacine can cause hypotension and bradycardia 1. While these effects are dose-dependent rather than timing-dependent, being aware of them during any medication adjustment is prudent.
Common pitfalls to avoid:
- Don't take doses at both times of day during the transition
- Don't reduce your dose when switching—maintain the same total daily amount
- Don't abruptly stop the medication if you experience initial drowsiness at night; this typically improves with continued use
What to Expect
The sedating effects that may have been problematic with morning dosing should now work in your favor by promoting sleep. Most patients tolerate bedtime dosing better, with 80% experiencing at least one treatment-emergent adverse event with guanfacine, but serious adverse events are rare 2. The somnolence and fatigue that occur frequently become therapeutic rather than problematic when timed with sleep.
Your ADHD symptom control should remain unchanged, as guanfacine's therapeutic effects on attention and impulsivity are maintained throughout the 24-hour period regardless of administration time 1.